![]() |
|
|
Vol. 62, Issue 5, 983-992, November 2002
Departments of Pharmacology and Medicine, School of Medicine, University of California, San Diego, La Jolla, California
| |
Abstract |
|---|
|
|
|---|
A number of different agonists activate G protein-coupled
receptors to stimulate adenylyl cyclase (AC), increase cAMP formation, and promote relaxation in vascular smooth muscle. To more fully understand this stimulation of AC, we assessed the expression, regulation, and compartmentation of AC isoforms in rat aortic smooth
muscle cells (RASMC). Reverse transcription-polymerase chain reaction
detected expression of AC3, AC5, and AC6 mRNA, whereas immunoblot
analysis indicated expression of AC3 and AC5/6 protein primarily in
caveolin-rich membrane (cav) fractions relative to noncaveolin (noncav)
fractions.
1-Adrenergic receptors (AR),
2AR, and Gs were detected in both cav and
noncav fractions, whereas the prostanoid receptors EP2R and
EP4R were excluded from cav fractions. We used an
adenoviral construct to increase AC6 expression. Overexpressed AC6
localized only in noncav fractions. Two-fold overexpression of AC6
caused enhancement of forskolin-, isoproterenol- and prostaglandin
E2-stimulated cAMP formation but no changes in basal levels
of cAMP. At higher levels of AC6 overexpression, basal and adenosine
receptor-stimulated cAMP levels were increased. Stimulation of cAMP
levels by agents that increase Ca2+ in native cells was
consistent with the expression of AC3, but overexpression of AC6, which
is inhibited by Ca2+, blunted the
Ca2+-stimulable cAMP response. These data indicate that: 1)
RASMC express multiple AC isoforms that localize in both caveolin-rich and noncaveolin domains, 2) expression of AC6 in non-caveolin-rich membranes can increase basal levels of cAMP and response to several stimulatory agonists, and 3) Ca2+-mediated regulation of
cAMP formation depends upon expression of different AC isoforms in
RASMC. Compartmentation of GPCRs and AC is different in cardiomyocytes
than in RASMC, indicating that targeting of these components to
caveolin-rich membranes can be cell-specific. Moreover, our results
imply that the colocalization of GPCRs and the AC isoforms they
activate need not occur in caveolin-rich fractions.
| |
Introduction |
|---|
|
|
|---|
Multiple
G protein-coupled receptors (GPCR) expressed in vascular smooth muscle,
including
-adrenergic receptors (
AR), can reduce vascular tone.
These GPCRs exert their effects by coupling to the heterotrimeric G
protein Gs and stimulating adenylyl cyclase (AC)
activity. Activity of AC in smooth muscle produces the second messenger
cAMP, which, via activation of protein kinase A, alters intracellular
Ca2+ dynamics and contractile function by
phosphorylating calcium channels, Ca2+-ATPases,
and myosin light-chain kinase (Nishikawa et al., 1984
; Lincoln and
Cornwell, 1991
; Somlyo and Somlyo, 1994
). In addition,
AR agonists
seem to induce relaxation via a cAMP- and PKA-independent mechanism in
smooth muscle from some tissues (Kume et al., 1994
; Ostrom and Ehlert,
1998
; Spicuzza et al., 2001
). Hypertension and aging both seem to be
associated with compromised
AR (and perhaps other GPCR)-mediated
signaling in vascular smooth muscle (Feldman, 1987
; Werstiuk and Lee,
2000
). This decrease in responsiveness to catecholamines is probably
attributable to several factors, including a decrease in
AR
expression, increased Gi protein and increased G
protein receptor kinase 2 expression (Anand-Srivastava, 1992
; Brodde
and Michel, 1992
; Gros et al., 2000
). Recent data document the fact
that increasing cellular expression of AC has the potential to improve
and restore
AR function in cardiovascular disease (Roth et al.,
1999
; Feldman, 2002
).
It has recently been appreciated that GPCRs and their associated
signaling components are not randomly dispersed throughout the
plasmalemma. In several cultured cell models and cardiac muscle cells,
expression of both
ARs and AC is enriched in distinct caveolin- and
sphingolipid/cholesterol-rich microdomains of the plasma membrane,
i.e., caveolae (Schwencke et al., 1999a
,b
; Ostrom et al., 2000b
, 2001
;
Rybin et al., 2000
). In these microdomains, one observes interaction
with (or retention of) proteins that have particular post-translational
modifications, such as palmitoylation (Shaul et al., 1996
). In
addition, caveolin in caveolae contains a binding ("scaffolding")
domain that interacts with certain signaling molecules, thereby
facilitating localization of such signaling molecules in caveolae.
Compartmentation of signaling molecules challenges the concept that
components of GPCR signal transduction are randomly distributed and
have extensive mobility in the plasma membrane. Instead, these sparsely
expressed proteins seem to be restricted to plasmalemmal microdomains,
probably facilitating rapid and specific signal transduction (Anderson,
1998
; Okamoto et al., 1998
; Ostrom et al., 2000a
).
In the present study, we tested the hypothesis that expression and localization of GPCRs and isoforms of AC might be critical determinants of how vascular smooth muscle cells respond to extracellular signals. We thus assessed GPCR-AC compartmentation in rat aortic smooth muscle cells (RASMC). Analysis of the expression of GPCR and AC isoforms in caveolin-rich membrane fractions from these cells shows that these proteins seem not to be as highly compartmentalized in these microdomains as such fractions from cardiomyocytes. Overexpression of different levels of a particular isoform of AC, AC6, altered both the regulation of basal levels of cAMP production and the coupling of GPCRs to cAMP generation. Furthermore, we observe that regulation of cAMP levels by intracellular Ca2+ concentrations in native RASMC is consistent with expression of a Ca2+-stimulable isoform of AC. We propose that GPCRs and postreceptor signaling components show differential, cell-specific patterns of subcellular compartmentation, implying that the determinants of such localization cannot be exclusively dependent upon primary structure of the interacting proteins but instead probably involves other, as-yet-unknown factors. Cellular compartmentation of AC isoforms and components that regulate their activity thus seem to be a means by which differentiated cells "tailor" their responses to extracellular and intracellular signals.
| |
Materials and Methods |
|---|
|
|
|---|
Materials and Cell Culture.
Primary antibodies for caveolin
isoforms and calmodulin-dependent kinase II (CaMK-II) were obtained
from BD PharMingen (San Diego, CA). Trp1 antibody was obtained from
Sigma (St. Louis, MO). EP2R and
EP4R primary antibodies were a generous gift from John W. Regan (University of Arizona, Tucson, AZ). All other antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The AC5/6
antibody from this commercial source does not distinguish between AC5
and AC6. Radiolabeled chemicals were obtained from PerkinElmer
Life Sciences. Other chemicals and reagents were obtained from Sigma.
RASMC were obtained from Dr. Wolfgang Dillmann (University of
California San Diego, La Jolla, CA). These cells were isolated from
thoracic aortas of 8- to 12-week-old male Sprague-Dawley rats
(Chamley-Campbell et al., 1979
; Seasholtz et al., 1999
). RASMC were
maintained in high-glucose DMEM with 16% fetal bovine serum and
penicillin/streptomycin and kept in a 37°C incubator with 10%
CO2 and were used between passages 5 and 12 for
all experiments.
-Galactosidase Staining.
Cells were incubated in growth
medium for 18 h with either vehicle or lacZ-expressing adenovirus
(1000-3000 viral particles/cell) then washed and equilibrated for
24 h. RASMC were then washed twice with PBS and fixative solution
(2% formaldehyde, 0.05% glutaraldehyde in PBS) for 5 min at room
temperature. Fixative solution was then aspirated, cells were washed 3 times with PBS and incubated with 5-bromo-4-chloro-3-indolyl-
-D-galactoside solution (5 mM
potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM
MgCl2, and 1 mg/ml 5-bromo-4-chloro-3-indolyl-
-D-galactoside in PBS) at
37°C for 3 to 6 h before visualization and documentation with a
light microscope and mounted 35-mm camera.
Reverse Transcriptase PCR.
Total RNA was extracted from
RASMC grown to 80 to 90% confluence on 10-cm plates using TRIzol
reagent (Invitrogen, Carlsbad, CA). A DNase reaction was
performed to eliminate DNA contaminants and the RNA was reverse
transcribed using Superscript II (Invitrogen) and poly(T) priming.
Primer pairs for each known isoform of AC were designed to unique
sequences in the highly homologous C1a or C2a regions of AC. PCR
reactions with each primer pair were performed on cDNA template,
genomic DNA (positive control) and minus RT (negative control)
template. Primer sequences used are shown in Table
1. PCR products were analyzed by agarose
gel electrophoresis and visualized under UV light with ethidium
bromide.
|
Membrane Fractionation.
Cells were fractionated using a
detergent-free method adapted from Song et al. (1996)
as described
previously (Ostrom et al., 2000b
). Two 15-cm plates containing 70 to
80% confluent RASMC were washed twice in ice-cold PBS and scraped into
a total of 2 ml of 500 mM sodium carbonate, pH 11. Cells were
homogenized with a tissue grinder with three 10-s bursts and then a
sonicator with three 20-s bursts. The homogenate was brought to 45%
sucrose by addition of an equal volume of 90% sucrose in MBS (25 mM
MES and 150 mM NaCl, pH 6.5) and loaded in an ultracentrifuge tube. A
discontinuous sucrose gradient was layered on top of the sample by
placing 4 ml of 35% sucrose prepared in MBS with 250 mM sodium carbonate then 4 ml of 5% sucrose (also in
MBS/Na2CO3). The gradient was centrifuged at 39,000 rpm on a SW41Ti rotor (Beckman Coulter, Fullerton, CA) for 16 to 18 h at 4°C. The top 2.0 ml of the
gradient were discarded and the faint light-scattering band was
collected from the 5 to 35% sucrose interface (caveolin-enriched
membranes). The bottom 4 ml of the gradient (45% sucrose) was
collected as noncaveolar membranes.
Purification of Nuclei. Approximately 30 million cells were washed twice with ice-cold PBS, then incubated in 5 ml of DMEM plus 10 µM cytochalasin B for 40 min at 37°C. The cells were washed twice with ice-cold PBS and scraped into 2 ml of PBS. The cells were centrifuged at 800g for 5 min to collect cells, and the supernatant was discarded. The pellet was resuspended in 2 ml of NB buffer (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, and protease inhibitor mix, pH 7.5) and centrifuged at 800g for 5 min. The supernatant was removed, and the pellet was resuspended in 1 ml of NB buffer containing 10 µM cytochalasin B and incubated on ice for 20 min. The cells were transferred to a chilled glass homogenizer and disrupted with 20 gentle strokes. The homogenate was transferred to a microcentrifuge tube, and 200 µl of NB buffer containing 40% sucrose was layered underneath the homogenate, then was centrifuged at 800g for 15min. The pellet was resuspended in 200 µl of PBS and analyzed by immunoblotting.
Measurement of Adenylyl Cyclase Activity.
AC activity was
measured in caveolin-3 immunoprecipitates as described previously
(Ostrom et al., 2001
). Briefly, cells were scraped and homogenized in a
modified Lysis buffer with a lower concentration of detergent (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM
EGTA, 2 mM DTT, and 0.5% Igepal CA-630, plus mammalian protease
inhibitor cocktail), incubated with caveolin-3 monoclonal antibody (BD
PharMingen) for 1 h, precipitated by incubation with protein
A-agarose then resuspended in membrane buffer (30 mM Na-HEPES, 5 mM MgCl2, 2 mM DTT, pH 7.5). Sample (30 µl; immunoprecipitate or supernatant) was added into tubes containing
30 mM Na-HEPES, 100 mM NaCl, 1 mM EGTA, 10 mM
MgCl2, 1 mM isobutylmethylxanthine, 1 mM ATP, 10 mM phosphocreatine, 5 µM GTP, 60 U/ml creatine phosphokinase, and
0.1% bovine serum albumin, pH 7.5, and drugs of interest. Tubes were
incubated for 15 min at 30°C and reaction was stopped by
boiling for 5 min. cAMP content of each tube was assayed for cAMP
content by radioimmunoassay as described previously (Ostrom et al.,
2000b
). Total protein concentration was determined using a dye-binding
protein assay (Bio-Rad, Hercules, CA).
Immunoprecipitation.
Immunoprecipitations were performed as
described previously (Ostrom et al., 2001
). Briefly, 15-cm plates of
RASMC were washed twice with cold PBS, scraped in 1 ml of Lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Igepal CA-630, plus mammalian
protease inhibitor cocktail) and homogenized in a Dounce homogenizer.
Samples were incubated with primary antibody for 1 to 3 h then
precipitated by incubating with protein A-agarose overnight. Pellets
were washed once in lysis buffer followed by washes in wash buffers 2 (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, and 0.2% Igepal CA-630) and 3 (10 mM Tris-HCl, pH 7.5, and 0.2% Igepal CA-630). Immunoprecipitated proteins were analyzed by immunoblot analysis.
Immunoblot Analysis. Individual fractions and whole cell lysates (WCL) were separated by SDS-polyacrylamide gel electrophoresis (Nu-PAGE, Invitrogen). Equal volumes of each fraction and a half-volume of WCL were loaded, resulting in approximately 6-fold lower amount of protein loaded in the cav fraction lanes. Proteins were transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA) by electroblotting. Membranes were blocked in 20 mM phosphate-buffered saline (PBS) with 3% nonfat dry milk and incubated with primary antibody (see Materials and Methods) overnight at 4°C. Bound primary antibodies were visualized using appropriate secondary antibody with conjugated horseradish peroxidase (Santa Cruz Biotechnology) and enhanced chemiluminescence reagent (Amersham Biosciences, Piscataway, NJ). Most primary antibodies recognized multiple nonspecific species. Only the band representing the appropriately sized molecule is shown. The amount of protein per fraction was determined using a dye-binding protein assay (Bio-Rad). In some cases, membranes were stripped using Re-Blot reagent (Chemicon International, Temecula, CA) and reprobed with another primary antibody.
Transmission Electron Microscopy. RASMCs were washed in PBS and fixed for 2 h with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (CB), then washed three times with CB and fixed with 1% osmium tetroxide (OsO4) in CB. Cells were washed briefly in CB and treated with 0.5% fresh tannic acid in CB. Dishes were additionally washed with CB followed by two washes with ddH20. EM blocks were stained with 2% uranyl acetate in 10% ethanol for 1 h at room temperature. The sections were then dehydrated through a standard series of 5 min each in 50%, 75%, 2× 95%, and 2× 100% ethanol/HPMA (1:1) then at 100% HPMA/LX112 (1:1) (Ladd Research Industries, Burlington, VT) followed by 1× at 100% LX112 for 10 min each. The dishes were then embedded in 100% fresh LX112, polymerized overnight at 60°C, sectioned, then stained with uranyl acetate and lead nitrate.
Measurement of cAMP Accumulation.
RASMC were incubated with
adenovirus for 24 h and then were washed extensively and allowed
to equilibrate in maintenance media for 24 h. Cells were washed
three times with serum- and NaHCO3-free DMEM
supplemented with 20 mM HEPES, pH 7.4, and equilibrated for 30 min.
Assay for cAMP accumulation was performed by incubation with drugs of
interest and 0.2 mM isobutylmethylxanthine, a cyclic nucleotide
phosphodiesterase inhibitor, for 10 min. In some experiments, an
alternative phosphodiesterase inhibitor, 10 µM Ro20-1724, was used
instead of isobutylmethylxanthine. Basal and agonist-stimulated cAMP
levels were similar in RASMC incubated with isobutylmethylxanthine and
Ro20-1724. To terminate reactions, assay medium was aspirated, and 250 µl of ice-cold trichloroacetic acid (7.5%, w/v) was
immediately added to each well. cAMP content in trichloroacetic acid
extracts was determined by radioimmunoassay, as described previously
(Ostrom et al., 2000b
). Production of cAMP was normalized to the amount of protein per sample as determined using a dye-binding protein assay
(Bio-Rad).
| |
Results |
|---|
|
|
|---|
AC Isoform Expression and Colocalization with GPCR.
A dearth
of information exists regarding the expression and localization of AC
isoforms in vascular smooth muscle cells. Therefore, we first performed
RT-PCR analysis with isoform-specific primers for all nine
transmembrane isoforms of AC, detecting only AC3, AC5, and AC6 mRNA in
RASMC (data not shown). Recent work has described that caveolae or
buoyant membrane fractions expressing caveolins, are enriched in
various signaling proteins, including AC, arguing for the existence of
distinct signaling microdomains in the plasmalemma (Anderson, 1998
;
Okamoto et al., 1998
; Schwencke et al., 1999a
,b
; Ostrom et al.,
2000a
,b
; Rybin et al., 2000
; Steinberg and Brunton, 2001
). Lipid raft
domains, which are enriched in cholesterol and sphingolipids but lack
caveolins, also contain signaling proteins (Oh and Schnitzer, 2001
). To
ascertain whether compartmentation of receptors, AC, and other key
signaling components play a role in the regulation of cAMP production
in RASMC, we used immunoblot analysis to assess expression of AC
isoforms,
-AR, G
s, and EP receptor isoforms
in caveolin-rich and noncaveolin membrane fractions. We isolated
caveolin-rich microdomains by fractionating RASMC in detergent-free
conditions [i.e., by using sonication in sodium carbonate (see
Materials and Methods)], and isolated buoyant membranes via
ultracentrifugation on a discontinuous sucrose gradient. Immunoblot
analyses were performed on these buoyant fractions (cav) as well as on
nonbuoyant fractions (noncav) and whole-cell lysate (WCL) from the same
cellular preparations. Cav fractions from these preparations contained
64.4 ± 3.6 µg protein, whereas the noncav fraction contained
760.8 ± 34.8 µg of protein. Approximately 6% of the total
cellular protein was recovered in the buoyant cav fraction. Equal
volumes of each fraction were loaded in adjacent lanes for separation
of proteins by SDS-PAGE and immunoblotting. Because the cav fraction
volume totals 2 ml and the noncav fraction totals 4 ml,
immunoreactivity for a protein equally distributed between the cav and
noncav fractions will seem 2-fold more intense in the cav lane.
-adaptin, a marker of clathrin-coated pits, and
calnexin, a marker of endoplasmic reticulum, was detected only in
noncav and WCL. Immunoblot analysis using antibodies specific for each
of the nine isoforms of AC detected only AC3 and AC5/6 (this latter
antibody does not distinguish between AC5 and AC6) in RASMC.
Immunoreactivity for both AC3 and AC5/6 was detectable primarily, but
not exclusively, in cav fractions in control RASMC (Figs. 1 and 6b).
The antibody for
1AR detected bands that
migrate at 96, 70, and 53 kDa primarily in noncav fractions (Fig. 1);
previous data indicate that these species all represent
1AR (Rybin et al., 2000
2AR and two prostanoid receptors,
EP2R and EP4R, were
detected solely in noncav fractions (Fig. 1). An antibody directed
toward the C-terminal of G
s primarily detected
a 44-kDa band, corresponding to the short form of this G protein, in
both cav and noncav fractions. Only a faint 52-kDa band, corresponding
to the long form of G
s, could be detected.
Therefore, several key GPCRs coupled to the stimulation of AC activity,
1AR ,
2AR,
EP2R, and EP4R, seem not to
be highly enriched in caveolin-rich membrane microdomains of RASMC.
|
AR and EPR subtypes were detected by
immunoblot analysis in non-nuclear membranes from RASMC (data not
shown). These data suggest that intracellular membranes or, more
probably, caveolin-poor plasma membrane regions express these GPCRs in
RASMC.
As a complementary approach, we investigated the colocalization of
components by performing immunoprecipitation followed by immunoblot
analysis. Caveolin-3 immunoprecipitates (Cav3 IP) from RASMC contained
AC3, AC5/6, and caveolin-3 immunoreactivity, but not immunoreactivity
for
1AR or
2AR (Fig.
2A). AC3 immunoprecipitates (AC3 IP) from
control RASMC also contained immunoreactivity for AC3, AC5/6, and
caveolin-3 but, in addition, displayed immunoreactivity for
1AR and
2AR. By
contrast, AC5/6 immunoprecipitates (AC5/6 IP; Fig. 2A) from RASMC
overexpressing AC6 (low-titer adenoviral incubation, see below)
contained immunoreactivity for
1AR,
2AR, and AC5/6 but not caveolin-3. Taken
together with the results shown in Fig. 1, these data indicate that
AR and native AC are not completely colocalized in control RASMC but
can colocalize in noncaveolin domains in RASMC that overexpress AC6.
|
AR immunoreactivity was difficult to detect in either the
pellet or supernatant. Forskolin-stimulated AC activity was detectable
in both cav and supernatant fractions; overexpression of AC6 increased
AC activity only in the supernatant fraction (Fig. 2b). These results
are consistent with a predominant localization of overexpressed AC6 in
noncaveolin-rich membrane domains.
Because primary cells in culture can rapidly lose their differentiated
phenotype, we examined RASMC morphology using transmission electron
microscopy. Ultrastructural examination of passage 5 RASMC indicated
that these cells possess both morphologic caveolae (light vesicular
structures, Fig. 3, top) and smooth
muscle contractile filaments (Fig. 3, bottom, arrow). These studies
indicate that cultured RASMC possess both caveolae and morphologic
features consistent with a contractile phenotype (Thyberg, 2000
|
AC6 Overexpression Enhances Basal and GPCR-Stimulated cAMP
Formation.
Multiple GPCRs that regulate cAMP formation are
expressed in vascular smooth muscle (Feldman and Gros, 1998
). To
determine the coupling of various GPCRs to a particular isoform of AC
in RASMC, we overexpressed AC6 using adenoviral gene delivery and then
measured the ability of various agonists to stimulate the formation of
cAMP. We first quantified the efficiency of gene delivery by adenovirus
in RASMC by exposing cells to various titers of AdV-lacZ for 24 h,
then fixed and stained cells for
-galactosidase activity. Sixty
percent of RASMC exposed to approximately 2000 viral particles/cell
AdV-lacZ stained for
-galactosidase activity, indicating that these
cells are moderately susceptible to gene delivery with adenovirus (Fig.
4A).
|
AR and EPR were detected (Fig. 1).
|
AR agonists represents the contribution of two
AR subtypes,
1AR and
2AR. To determine the effect of AC6
overexpression on the responses mediated by the two major
AR
subtypes in these cells, we used low titer AC6 adenovirus and measured
cAMP production stimulated by various concentrations of isoproterenol
in the presence of either a
1AR or
2AR-selective antagonist, thus "isolating" responses to each of the receptor subtypes. Isoproterenol-stimulated cAMP production in the presence of ICI-118,551 (0.1 µM, a
2AR-selective antagonist) displayed an
EC50 of 5.0 ± 2.09 µM and a maximum of 28.0 ± 10.8 pmol of cAMP/mg of protein (Fig. 5B). This same
response in AC6 overexpressing RASMC was similar in potency
(EC50 = 4.0 ± 1.66 µM) but had a 1.8-fold
higher maximal response (49.5 ± 12.9 pmol/mg of protein).
Isoproterenol-stimulated cAMP production in the presence of CGP-20712A
(0.1 µM, a
1AR-selective antagonist) displayed an EC50 of 1.3 ± 1.66 µM and a
maximum of 49.5 pmol cAMP/mg of protein. This response in AC6
overexpressing cells was similar in potency (EC50 = 1.0 ± 1.23 µM) but had a 2.1-fold higher maximal response
(160 ± 13.3 pmol/mg of protein). These data indicate that
1AR- and
2AR-mediated
responses, and by inference, coupling of the two
AR subtypes to the
additional AC6, are similar in RASMC. Moreover, as indicated above,
RASMC in which we expressed AC6 using an adenoviral AC6 construct
showed increased AC5/6 immunoreactivity primarily in noncav fractions
and whole-cell lysate (Figs. 1 and 2A). Expression levels and
localization of
1AR,
2AR, EP2R,
EP4R, G
s, and AC3 were
not altered in RASMC overexpressing AC6 (data not shown).
|
Calcium-Stimulated cAMP Formation via AC3.
Contractile tone in
smooth muscle is regulated by intracellular Ca2+
concentrations ([Ca2+]i),
which activate the contractile machinery, and cAMP, which inhibits
contraction via PKA-dependent phosphorylation of myosin light-chain
kinase and activation of Ca2+ uptake via
sarcoplasmic Ca2+-ATPases (Nishikawa et al.,
1984
; Lincoln and Cornwell, 1991
). Cross talk between increased
[Ca2+]i and cellular
generation of cAMP probably depends upon the isoforms of AC expressed
(Hanoune and Defer, 2001
). Some isoforms (AC1, AC3, and AC8) are
stimulated by Ca2+, whereas others (AC5 and AC6)
are inhibited by Ca2+ (Bakalyar and Reed, 1990
;
Tang and Gilman, 1992
; Hanoune and Defer, 2001
) However, AC3 can also
be inhibited by increases in [Ca2+]i via activation of
CaMK-II (Wei et al., 1996
). Therefore, we measured the effects of
agents that can increase
[Ca2+]i on cAMP
production in RASMC to determine the interaction between these two
critical messengers. The Ca2+ ionophore,
ionomycin, increased basal cAMP accumulation but did not increase or
decrease either isoproterenol or PGE2-stimulated cAMP levels (Fig. 6A).
|
| |
Discussion |
|---|
|
|
|---|
There has been growing interest in caveolin-rich domains (e.g.,
caveolae), as plasma membrane microdomains that seem to attract and
retain certain signaling molecules (Okamoto et al., 1998
; Ostrom et
al., 2000a
; Simons and Toomre, 2000
; Galbiati et al., 2001
). Spatial
organization of multiple component signal transduction cascades
provides a means to generate signals with high fidelity and efficiency.
Therefore, the goal of the present study was to characterize the
compartmentation of GPCR-AC signaling components in primary cultures of
vascular smooth muscle cells, RASMC.
Our results show that in RASMC, AC3 and AC5/6 are predominant AC
isoforms preferentially expressed in caveolin-rich fractions, whereas
several GPCRs, including
1AR,
2AR, EP2R, and
EP4R, are substantially localized in noncav
fractions. Increased expression of AC6 localized primarily to noncav
fractions and enhanced cAMP formation in response to agonists for
several GPCRs. Low levels of AC6 overexpression did not enhance basal
levels of cAMP or responses to another GPCR that increases cellular
cAMP production, the adenosine A2b receptor [the
subtype expressed in RASMC (Dubey et al., 2000
; Peyot et al., 2000
)].
In contrast, higher levels of AC6 overexpression enhanced basal and
A2b receptor responses, thereby implying
differences in receptor coupling and regulation of AC6 that depend upon
amount of the effector enzyme. These results contrast with those from
studies of cardiomyocytes, where up to 10-fold increases in AC6
expression do not increase basal levels of cAMP production (Gao et al.,
1998
; Ostrom et al., 2000b
). Overexpressed AC6 localizes similarly to
endogenous AC6 in cardiomyocytes while in RASMC overexpressed AC6 does
not (Ostrom et al., 2001
; Ostrom et al., 2000b
).
It is curious that endogenous AC5/6 localizes in caveolin-rich fractions while overexpressed AC6 protein does not. The reason for this is unknown, but there are several possible explanations. One is that RASMC predominantly express AC5 protein, which localizes differently than AC6. Because no antibody is currently available to distinguish AC5 and AC6 protein, this hypothesis cannot be tested. RT-PCR studies showed expression of both AC5 and AC6 mRNA in RASMC. A second possibility relates to mechanisms that govern AC localization to caveolin-rich fractions; such mechanisms remain poorly defined. AC6 localizes to caveolin-rich fractions in native RASMC, but these cells may lack the capacity to appropriately localize additional AC6 protein. These results thus highlight a potential pitfall of studies using exogenously expressed proteins to assess localization of native proteins.
The present findings contrast with previous work on cardiomyocytes in
another way. Cardiomyocyte AC5/6 and
AR are both predominantly localized in cav fractions (Ostrom et al., 2001
; Ostrom et al., 2000b
;
Rybin et al., 2000
). Thus, comparison of the two cell types suggests
that both
AR and AC isoforms can partition into buoyant, caveolin-rich membrane fractions in a cell-specific manner (Table 3). Although different patterns of
protein expression in various cell types are responsible for their
differentiated state and specialized cellular functions, we speculate
that the localization of AC and the components that influence AC
activity in different cells might help "tailor" the ability of
cells to respond to extracellular and intracellular signals by defining
a precise environment in which the second messenger will be generated.
The precise nature and action of factors that serve as determinants of
such cell-specific localization remain to be identified. Because
high-level AC6 overexpression in cardiomyocytes localizes in
caveolin-rich fractions (Ostrom et al., 2000b
; 2001
; Rybin et al.,
2000
), cardiomyocytes and RASMC must differ in their capacity to
appropriately localize overexpressed AC6.
|
This spatial organization of signaling is likely to be an important
factor in vascular smooth muscle cell regulation, in particular with
respect to regulation of cAMP formation, which leads to decreased contractile tone, decreased vascular resistance and decreased blood
pressure (Werstiuk and Lee, 2000
). In addition, the AC isoforms expressed by vascular smooth muscle are probably key determinants of
the regulation of cAMP production because different isoforms can be
regulated in an opposite manner by various cellular signals such as
Ca2+ and G
(Hanoune
and Defer, 2001
). Therefore, the identity of the AC isoform expressed,
combined with the colocalization of the isoform with the source of
other signals that regulate its activity, dictates both basal cAMP
levels and the hormonal signals that stimulate or inhibit AC activity
(Fagan et al., 2000
; Smith et al., 2002
). The importance of caveolae in
smooth muscle regulation has also been suggested by evidence that GPCRs
that link to other signaling pathways are enriched in caveolae
(Ishizaka et al., 1998
; Taggart, 2001
; Ushio-Fukai et al., 2001
).
AC3 is generally regarded as a Ca2+-stimulable
isoform; however, increases in
[Ca2+]i can inhibit AC3
activity due to phosphorylation by CamK-II (Wei et al., 1996
). RASMC
exhibit Ca2+-stimulable AC activity, as evidenced
in the present studies (Fig. 6) and by the findings of Zhang et al.
(1997)
, who reported that vasopressin enhances
AR-stimulated cAMP
formation in a Ca2+-dependent manner in RASMC.
Lack of Ca2+-mediated inhibition of cAMP in the
present studies may be due to the poor colocalization of AC3 with the
Ca2+ entry channel (Trp1) and CamK-II, which are
probably required for the regulation of AC activity. Without sufficient
colocalization of Trp1 and CamK-II, the direct stimulatory effect of
Ca2+ may predominate and cause activation of AC3
(Fig. 6).
PGE2, a major product of arachidonic acid
metabolism by cyclooxygenases, potently activates the EP subfamily of
prostanoid receptors. Of the four receptors in the EP class,
EP2 and EP4 characteristically couple to G
s and the
stimulation of cAMP production and are expressed in smooth muscle from
many vascular beds (Breyer et al., 2001
). Wong et al. (2001)
recently
reported that PGE2 activation of both cAMP
generation and concomitant inhibition of vascular smooth muscle cell
proliferation were diminished in AC3 knockout animals, implying that
receptors activated by PGE2 could only couple to
AC3. In the present studies, we find that receptors on which
PGE2 acts can couple to AC6 when this AC isoform is overexpressed in RASMC. Our results suggest that
EP2R and EP4R may not
couple efficiently to AC3 in RASMC because of their lack of
colocalization (Fig. 4). However, inconsistencies between our results
in RASMC and those of Wong et al. (who studied human fetal and adult
mouse aortic smooth muscle) may relate to cell-specific or species
differences in expression and localization of these various signaling components.
One key caveat of the present work is that the colocalization of
proteins that we studied relies upon isolation of buoyant membrane
fractions. The membrane fractions isolated in this way are not
exclusively morphologic caveolae, and may include additional microdomains of the cell (e.g., lipid rafts) (Simons and Toomre, 2000
;
Galbiati et al., 2001
; Oh and Schnitzer, 2001
). Definitive proof of
colocalization of receptors and AC will probably require additional
approaches, such as studies at the electron microscopic level, similar
to those in Fig. 3, c and d. Unfortunately, antibodies presently
available for GPCR and AC are of limited usefulness for these types of
studies (data not shown). These studies only examined the localization
of GPCR signaling components in quiescent cells. It will be important
to understand the location of these GPCR and other proteins after
activation by agonists.
In conclusion, these studies of GPCR-AC signal transduction in RASMC provide new information regarding subcellular localization and compartmentation of these signaling components that regulate smooth muscle function. The colocalization of GPCR signaling components in plasmalemmal microdomains has important implications for the regulation of cellular, in particular smooth muscle cell, responses to extracellular hormones and neurotransmitters. Most previous work that has examined mechanisms of signal transduction has emphasized isolation, purification, cloning, and reconstitution of purified components. The studies described here emphasize the potentially critical role of spatial organization of key signaling molecules in helping to define the manner by which vascular smooth muscle cells respond to extracellular and intracellular stimuli. Moreover, the findings indicate cell-specific differences in the identity of signaling molecules in membrane microdomains, in particular caveolin-rich domains.
| |
Acknowledgments |
|---|
We are grateful to Dr. John W. Regan (University of Arizona) for providing EP2R and EP4R antibodies and to Dr. Marilyn G. Farquhar and Ingrid Neisman for assistance with electron microscopy. We also express our gratitude to Dr. Wolfgang Dillmann (University of California San Diego) for providing cells and Linda Pan and Miki Hase for assistance with cell culture. We wish to also acknowledge Ryan M. Drenan for his help with RT-PCR.
| |
Footnotes |
|---|
Received March 1, 2002; Accepted July 24, 2002
This work was supported by National Institutes of Health grants HL63885 and HL53773.
R.S.O. and X.L. contributed equally to this work.
Address correspondence to: Rennolds S. Ostrom, Ph.D., Department of Pharmacology, 9500 Gilman Drive, La Jolla, CA 92093-0636. E-mail: rostrom{at}ucsd.edu
| |
Abbreviations |
|---|
GPCR, G protein-coupled receptor; AR, adrenergic computer; AC, adenylyl cyclase; RASMC, rat aortic smooth muscle cells; CaMK, calmodulin-dependent kinase II; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; MES, 2-[N-morpholino]ethanesulfonic acid; MBS, MES-buffered saline; DTT, dithiothreitol; NB, nuclei buffer; WCL, whole-cell lysates; CB, cacodylate buffer; HPMA, hydroxypropyl methacrylate; Ro20-1724, 4-(3-butoxy-4-methoxybenzyl)2-imidazolidinone; EPxR, prostanoid EP receptor (x = 2 or 4); NECA, 5'-N-ethylcarboxamidoadenosine; PGE, prostaglandin E; ICI-118,551, (±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3[(1-methylethyl)amino]-2-butanol; CGP-20712A, [2-(3-carbamoyl-4-hydroxyphenoxy)-ethylamino]-3-[4-(1-methyl-4-trifluormethyl-2-imidazolyl)-phenoxy]-2-propanolmethanesulfonate.
| |
References |
|---|
|
|
|---|
-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.
Mol Pharmacol
57:
1075-1079
-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway.
J Biol Chem
275:
41447-41457This article has been cited by other articles:
![]() |
L. I. Jiang, J. Collins, R. Davis, I. D. Fraser, and P. C. Sternweis Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VII J. Biol. Chem., August 22, 2008; 283(34): 23429 - 23439. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Head, H. H. Patel, Y. M. Tsutsumi, Y. Hu, T. Mejia, R. C. Mora, P. A. Insel, D. M. Roth, J. C. Drummond, and P. M. Patel Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellul |